We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How a product complies with EU safety, health and environmental requirements, and how to place a CE marking on your product.
Comply with good manufacturing practice (GMP) and good distribution practice (GDP), and prepare for an inspection.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Impact assessment opinions that are not 'fit for purpose' based on external, independent scrutiny of new regulation by the Regulatory Policy Committee.
Find out when you can zero rate books and other forms of printed matter.
Impact assessment opinions based on external, independent scrutiny of new regulation by the Regulatory Policy Committee.
Details of certificates issued under the Special Import System for the top ten imported veterinary medicines 1 April - 30 June 2023.
Find out how to apply VAT zero rating for the supply of those plants and seeds that are used to grow food for human consumption.
Using an ecological momentary assessment to evaluate your digital health product.
How to use a behaviour change techniques review to evaluate your digital health product.
How to use feedback from marketplace reviews to evaluate your digital health product.
Guidance for suppliers and dealers.
How a marketing authorisation holder should report a defect with a veterinary medicine.
This guidance provides information on comparator products used in studies supporting abridged marketing authorisation applications
How the MHRA makes decisions on what is a medicinal product (borderline products).
Evaluations made by the Rapid Review Panel (RRP) on submitted products.
Impact assessment opinions that are not 'fit for purpose' based on external, independent scrutiny of new regulation by the Regulatory Policy Committee
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).